NKX2-1 and cancer: Determine the therapeutic vulnerabilities of NKX2‐1‐driven cancersTest whether NKX2‐1 expressing cancer cells are more sensitive to serine/glycine synthesis inhibition using repurposed drugs such as sertralineEvaluate the effectiveness of chemotherapy (etoposide) in treating NKX2‐1 driven cancers